A Phase 3 Study of 99mTC-EC-DG SPECT/CT Versus PET/CT in Lung Cancer

Part of paid clinical trials in Decatur, Illinois.

Sponsor
Cell>Point LLC
Study ID
NCT01394679
Phase
PHASE3
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • (99m Tc) ECDG (Ethylenedicysteine-Deoxyglucose) — DRUG
    One injection of Technetium-99m Ethylenedicysteine-Deoxyglucose to yield a target dose of 25 mCi (range of 20-30 mCi)by IV push and less than 1 mg of EC-DG
  • 18 F FDG followed by PET/CT imaging — DRUG
    Single injection of 18 F FDG range of 10-20 mCi

Study Details

The purpose of this study is to determine if the images of the primary lesions of lung cancer and any metastatic lesions seen from the investigational SPECT/CT 99mTC-EC-DG scans are the same as the PET/CT 18F-FDG scans.

Key Dates

Start date
May 1, 2025
Status verified
Mar 2025
Primary completion
Dec 31, 2025
Completion
Dec 31, 2026

Study Design

Enrollment
154 participants (estimated)
Allocation
NON_RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
DIAGNOSTIC

Arms

  • Active Comparator: 18-F-FDG Imaging Agent
    18 F FDG followed by PET/CT imaging
  • Experimental: 99m Tc-EC-DG imaging agent
    99m Tc-EC-DG injection followed by SPECT/CT imaging (target of 20-30 mCi of Tc)and \< 1 mg EC-DG

Primary Outcome Measure

Efficacy:Comparison of 99mTc-EcC-DG SPECT/CT images to 18F-FDG PET/CT images of primary lung cancer lesion and metastatic lesions [ Time Frame: Images will be compared at the core image lab at approximately every 4 to 6 weeks ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Decatur Memorial HospitalDecaturIllinois62526-

Find similar trials in Decatur, IL

By condition

Related Studies